NewslettersESC & iPSC NewsHuman Immunology NewsImmune Regulation NewsPancreatic Cell News Engineering of Immune Checkpoints B7-H3 and CD155 Enhances Immune Compatibility of MHC-I−/− iPSCs for β Cell Replacement By Bob - September 27, 2022 0 By profiling the relevant NK-activating ligands on iPSCs during in vitro differentiation into pancreatic β cells, researchers found that they express high levels of B7-H3 and CD155. [Cell Reports] AbstractFull ArticleGraphical Abstract